Efficacy and safety of dulaglutide: a novel once-weekly glucagon-like peptide-1 analogue
GLP-1 receptor agonists are a class of drugs with high efficacy, a good safety profile recommended as second-line drugs after metformin for the treatment of type 2 diabetes mellitus. Dulaglutide is a GLP-1 analogue designed for once weekly subcutaneous injection using recombinant technology and appr...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
Remedium Group LLC
2018-03-01
|
| Sarja: | Медицинский совет |
| Aiheet: | |
| Linkit: | https://www.med-sovet.pro/jour/article/view/2329 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|